Regen BioPharma Inc Quarterly Net Cash Provided by (Used in) Investing Activities in USD from Q4 2017 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Regen BioPharma Inc quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q4 2017 to Q4 2022.
  • Regen BioPharma Inc Net Cash Provided by (Used in) Investing Activities for the quarter ending December 31, 2022 was $0.000.
  • Regen BioPharma Inc annual Net Cash Provided by (Used in) Investing Activities for 2022 was $25K, a 94.9% decline from 2021.
  • Regen BioPharma Inc annual Net Cash Provided by (Used in) Investing Activities for 2021 was $495K.
  • Regen BioPharma Inc annual Net Cash Provided by (Used in) Investing Activities for 2020 was $0.000, a 100% decline from 2019.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $0 $0 Oct 1, 2022 Dec 31, 2022 10-Q 2023-01-19
Q4 2021 $0 $0 Oct 1, 2021 Dec 31, 2021 10-Q 2023-01-19
Q4 2020 $0 $0 Oct 1, 2020 Dec 31, 2020 10-Q 2021-08-13
Q4 2019 $0 -$49.9K -100% Oct 1, 2019 Dec 31, 2019 10-Q 2021-08-13
Q4 2018 $49.9K +$49.9K Oct 1, 2018 Dec 31, 2018 10-Q 2021-08-05
Q4 2017 $0 Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.